{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T15:12:53Z","timestamp":1774278773398,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T00:00:00Z","timestamp":1587340800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Ferring Pharmaceuticals A\/S, Copenhagen, Denmark"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.peptides.2020.170318","type":"journal-article","created":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T03:06:22Z","timestamp":1587524782000},"page":"170318","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Selepressin, a novel selective V1A receptor agonist: Effect on mesenteric flow and gastric mucosa perfusion in the endotoxemic rabbit"],"prefix":"10.1016","volume":"129","author":[{"given":"St\u00e9phane P.","family":"Milano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier B.","family":"Boucheix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torsten M.","family":"Reinheimer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.peptides.2020.170318_bib0005","doi-asserted-by":"crossref","first-page":"E90","DOI":"10.3390\/healthcare6030090","article-title":"The \"Centrality of Sepsis\": a review on incidence, mortality, and cost of care","volume":"6","author":"Hajj","year":"2018","journal-title":"Healthcare (Basel)"},{"key":"10.1016\/j.peptides.2020.170318_bib0010","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S2213-2600(18)30063-8","article-title":"The global burden of paediatric and neonatal sepsis: a systematic review","volume":"6","author":"Fleischmann-Struzek","year":"2018","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.peptides.2020.170318_bib0015","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ccc.2017.08.005","article-title":"Pathophysiology of septic shock","volume":"34","author":"Russell","year":"2018","journal-title":"Crit. Care Clin."},{"key":"10.1016\/j.peptides.2020.170318_bib0020","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1089\/sur.2017.278","article-title":"Sepsis 2018: definitions and guideline changes","volume":"19","author":"Napolitano","year":"2018","journal-title":"Surg. Infect. (Larchmt)"},{"key":"10.1016\/j.peptides.2020.170318_bib0025","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/CCM.0000000000002255","article-title":"Surviving Sepsis campaign: international guidelines for management of Sepsis and septic shock: 2016","volume":"45","author":"Rhodes","year":"2017","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.peptides.2020.170318_bib0030","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/978-0-387-73657-0_220","article-title":"Synthesis and in vitro pharmacological profile of potent and selective peptidic V1a receptor agonists","volume":"611","author":"Wisniewski","year":"2009","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.peptides.2020.170318_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5049\/EBP.2015.13.1.1","article-title":"A minireview on vasopressin-regulated aquaporin-2 in kidney collecting duct cells","volume":"13","author":"Park","year":"2015","journal-title":"Electrolyte Blood Press."},{"key":"10.1016\/j.peptides.2020.170318_bib0040","article-title":"Factor VIII is synthesized in human endothelial cells, packaged in Weibel-Palade bodies and secreted bound to ULVWF strings","volume":"16","author":"Turner","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.peptides.2020.170318_bib0045","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1186\/cc2894","article-title":"Bench-to-bedside: sepsis is a disease of the microcirculation","volume":"8","author":"Spronk","year":"2004","journal-title":"Crit. Care"},{"key":"10.1016\/j.peptides.2020.170318_bib0050","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13613-015-0058-8","article-title":"Timing and causes of death in septic shock","volume":"5","author":"Daviaud","year":"2015","journal-title":"Ann. Intensive Care"},{"key":"10.1016\/j.peptides.2020.170318_bib0055","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1124\/jpet.111.178848","article-title":"Pharmacological characterization of FE 202158, a novel, potent, selective, and short-acting peptidic vasopressin V1a receptor full agonist for the treatment of vasodilatory hypotension","volume":"337","author":"Laporte","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.peptides.2020.170318_bib0060","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s13054-017-1798-7","article-title":"Selepressin, a novel selective vasopressin V1A agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patients","volume":"21","author":"Russell","year":"2017","journal-title":"Crit. Care"},{"key":"10.1016\/j.peptides.2020.170318_bib0065","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1513\/AnnalsATS.201708-669SD","article-title":"Rationale and design of an adaptive phase 2b\/3 clinical trial of selepressin for adults in septic shock. Selepressin evaluation programme for sepsis-induced shock-adaptive clinical trial","volume":"15","author":"Lewis","year":"2018","journal-title":"Ann. Am. Thorac. Soc."},{"key":"10.1016\/j.peptides.2020.170318_bib0070","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1164\/ajrccm.158.2.9710092","article-title":"Increased intestinal permeability is associated with the development of multiple organ dysfunction syndrome in critically ill ICU patients","volume":"158","author":"Doig","year":"1998","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.peptides.2020.170318_bib0075","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1096\/fasebj.14.9.1093","article-title":"Catecholamines up-regulate lipopolysaccharide-induced IL-6 production in human microvascular endothelial cells","volume":"14","author":"Gornikiewicz","year":"2000","journal-title":"FASEB J."},{"key":"10.1016\/j.peptides.2020.170318_bib0080","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1097\/00003246-199807000-00023","article-title":"Effect of acute-phase and heat-shock stress on apoptosis in intestinal epithelial cells (Caco-2)","volume":"26","author":"Swank","year":"1998","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.peptides.2020.170318_bib0085","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0014-2999(99)00004-7","article-title":"Vasopressin increases vascular endothelial growth factor secretion from human vascular smooth muscle cells","volume":"368","author":"Tahara","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.peptides.2020.170318_bib0090","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1113\/expphysiol.2014.080952","article-title":"Vasopressin regulation of epithelial colonic proliferation and permeability is mediated by pericryptal platelet-derived growth factor A","volume":"99","author":"Mir\u00f3","year":"2014","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.peptides.2020.170318_bib0095","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1177\/0310057X0603400408","article-title":"Effect of low-dose vasopressin infusion on vital organ blood flow in the conscious normal and septic sheep","volume":"34","author":"Di Giantomasso","year":"2006","journal-title":"Anaesth. Intensive Care"},{"key":"10.1016\/j.peptides.2020.170318_bib0100","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/01.CCM.0000104201.62736.12","article-title":"Arginine vasopressin compromises gut mucosal microcirculation in septic rats","volume":"32","author":"Westphal","year":"2004","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.peptides.2020.170318_bib0105","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/01.CCM.0000152253.45901.FB","article-title":"Low-dose terlipressin during long-term hyperdynamic porcine endotoxemia: effects on hepatosplanchnic perfusion, oxygen exchange, and metabolism","volume":"33","author":"Asfar","year":"2005","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.peptides.2020.170318_bib0110","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1161\/01.CIR.0000066692.71008.BB","article-title":"Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study","volume":"107","author":"D\u00fcnser","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.peptides.2020.170318_bib0115","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00134-003-2094-3","article-title":"Effects of terlipressin on systemic and regional haemodynamics in catecholamine-treated hyperkinetic septic shock","volume":"30","author":"Morelli","year":"2004","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.peptides.2020.170318_bib0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0165422","article-title":"Selepressin and Arginine Vasopressin do not display cardiovascular risk in atherosclerotic rabbit","volume":"11","author":"Boucheix","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.peptides.2020.170318_bib0125","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/CCM.0000000000001380","article-title":"A selective V(1A) receptor agonist, selepressin, is superior to arginine vasopressin and to norepinephrine in ovine septic shock","volume":"44","author":"He","year":"2016","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.peptides.2020.170318_bib0130","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/SHK.0000000000000426","article-title":"Norepinephrine: not too much, too long","volume":"44","author":"Martin","year":"2015","journal-title":"Shock"},{"key":"10.1016\/j.peptides.2020.170318_bib0135","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s00134-008-1058-z","article-title":"Systemic and hepatosplanchnic macro- and microcirculatory dose response to arginine vasopressin in endotoxic rabbit","volume":"34","author":"Kopel","year":"2008","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.peptides.2020.170318_bib0140","article-title":"Effects of dobutamine on gut mucosal nitric oxide production during endotoxic shock in rabbits","volume":"15","author":"Lobo","year":"2009","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.peptides.2020.170318_bib0145","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1440-1681.1997.tb01791.x","article-title":"Interactions between vasopressin and baroreflex control of the sympathetic nervous system","volume":"24","author":"Hasser","year":"1997","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.peptides.2020.170318_bib0150","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1046\/j.1540-8191.2002.01002.x","article-title":"Vasopressin therapy for vasoplegic syndrome following cardiopulmonary bypass","volume":"17","author":"Masetti","year":"2002","journal-title":"J. Card. Surg."},{"key":"10.1016\/j.peptides.2020.170318_bib0155","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0003-4975(99)01197-2","article-title":"Arginine vasopressin in the treatment of 50 patients with postcardiotomy vasodilatory shock","volume":"69","author":"Morales","year":"2000","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.peptides.2020.170318_bib0160","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/CCM.0b013e31827e83af","article-title":"Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup, surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012","volume":"41","author":"Dellinger","year":"2013","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.peptides.2020.170318_bib0165","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00540-010-0934-1","article-title":"Comparison of the effects of vasopressin and norepinephrine on organ perfusion during septic shock in streptozotocin-induced diabetic rats","volume":"24","author":"Hinohara","year":"2010","journal-title":"J. Anesth."},{"key":"10.1016\/j.peptides.2020.170318_bib0170","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1152\/japplphysiol.00017.2003","article-title":"Vasopressin vs. Norepinephrine in endotoxic shock: systemic, renal and splanchnic hemodynamic and oxygen transport effects","volume":"95","author":"Guzman","year":"2003","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.peptides.2020.170318_bib0175","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1007\/s00134-003-1736-9","article-title":"Norepinephrine and vital organ blood flow during experimental hyperdynamic sepsis","volume":"29","author":"Di Giantomasso","year":"2003","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.peptides.2020.170318_bib0180","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1046\/j.1538-7836.2003.00190.x","article-title":"Cellular mechanisms of the hemostatic effects of desmopressin (DDAVP)","volume":"1","author":"Kaufmann","year":"2003","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.peptides.2020.170318_bib0185","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/00005344-199402000-00023","article-title":"Nitric oxide may participate in V2 vasopressin-receptor-mediated renal vasodilation","volume":"23","author":"Aki","year":"1994","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.peptides.2020.170318_bib0190","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/0022-4804(90)90260-9","article-title":"Laboratory models of sepsis and septic shock","volume":"49","author":"Fink","year":"1990","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.peptides.2020.170318_bib0195","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40560-016-0146-3","article-title":"Role of kidney injury in sepsis","volume":"4","author":"Doi","year":"2016","journal-title":"J. Intensive Care"},{"key":"10.1016\/j.peptides.2020.170318_bib0200","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1172\/JCI112413","article-title":"Vasopressin reduces cardiac function and augments cardiopulmonary baroreflex resistance increases in man","volume":"77","author":"Ebert","year":"1986","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.peptides.2020.170318_bib0205","first-page":"H734","article-title":"Direct cardiac effects of vasopressin and their reversal by a vascular antagonist","volume":"251","author":"Boyle","year":"1986","journal-title":"Am. J. Physiol."}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019697812030067X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019697812030067X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T09:25:57Z","timestamp":1759310757000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019697812030067X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":41,"alternative-id":["S019697812030067X"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2020.170318","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selepressin, a novel selective V1A receptor agonist: Effect on mesenteric flow and gastric mucosa perfusion in the endotoxemic rabbit","name":"articletitle","label":"Article Title"},{"value":"Peptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.peptides.2020.170318","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Ferring Pharmaceuticals A\/S. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"170318"}}